Examination of in vitro epithelial cell lines as models for Francisella tularensis non-phagocytic infections

Journal of Microbiological Methods

Volumn 93, Issue 2, 2013, Pages 153-160

  Lo, Karen Yi Shyuan ^a   Chua, Michael Dominic ^a   Abdulla, Salima ^a   Law, H T ^a   Guttman, Julian Andrew ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Bacteria; Francisella novicida; Immunolocalization; Invasion; Replication

Indexed keywords

ANIMAL CELL; ARTICLE; BACTERIAL LOAD; CELL CULTURE; CELL DIVISION; CELL INVASION; CELL STRAIN COS7; CELL STRAIN HEK293; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IN VITRO STUDY; INCUBATION TIME; INTRACELLULAR BACTERIUM; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; TULAREMIA;

ANIMALS; BACTERIAL LOAD; CELL LINE; CYTOPLASM; ENDOCYTOSIS; EPITHELIAL CELLS; FRANCISELLA TULARENSIS; HUMANS;

BACTERIA (MICROORGANISMS); FRANCISELLA TULARENSIS; FRANCISELLA TULARENSIS SUBSP. NOVICIDA;

EID: 84876372321     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2013.03.004     Document Type: Article

References (28)

1. Ahmad S., Hunter L., Qin A., Mann B., van Hoek M.L. Azithromycin effectiveness against intracellular infections of Francisella. BMC Microbiol. 2010, 10(1):123.
2. Al-Khodor S., Abu Kwaik Y. Triggering Ras signalling by intracellular Francisella tularensis through recruitment of PKCα and βI to the SOS2/GrB2 complex is essential for bacterial proliferation in the cytosol. Cell. Microbiol. 2010, 12(11):1604-1621.
3. Champion M.D., et al. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. PLoS Pathog. 2009, 5(5):e1000459. D.S. Guttman (Ed.).
4. Chiba H., Osanai M., Murata M., Kojima T., Sawada N. Transmembrane proteins of tight junctions. Biochim. Biophys. Acta Biomembr. 2008, 1778(3):588-600.
5. Conlan J.W., Chen W., Shen H., Webb A., KuoLee R. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb. Pathog. 2003, 34(5):239-248.
6. Dennis D.T., et al. Tularemia as a biological weapon medical and public health management. JAMA 2001, 285(21):2763-2773.
7. Dienst F.T.J. Tularemia: a perusal of three hundred thirty-nine cases. J. La State Med. Soc. 1963, 115:114-127.
8. Eigelsbach H.T., Downs C.M. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J. Immunol. 1961, 87:415-425.
9. Feldman K.A., et al. An outbreak of primary pneumonic tularemia on Martha's vineyard. N. Engl. J. Med. 2001, 345(22):1601-1606.
10. Francis E. A summary of present knowledge of tularaemia. Medicine 1928, 7(4):411-432.
11. George C.H., Kendall J.M., Campbell A.K., Evans W.H. Connexin-aequorin chimerae report cytoplasmic calcium environments along trafficking pathways leading to gap junction biogenesis in living COS-7 cells. J. Biol. Chem. 1998, 273(45):29822-29829.
12. Hall J.D., et al. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect. Immun. 2008, 76(12):5843-5852.
13. Hong T., Gurian P.L., Huang Y., Haas C.N. Prioritizing risks and uncertainties from intentional release of selected Category A pathogens. PLoS One 2012, 7(3):e32732.
14. Horzempa J., O'Dee D.M., Shanks R.M.Q., Nau G.J. Francisella tularensis pyrF Mutants show that replication in nonmacrophages is sufficient for pathogenesis in vivo. Infect. Immun. 2010, 78(6):2607-2619.
15. Inai T., Sengoku A., Hirose E., Iida H., Shibata Y. Freeze-fracture electron microscopic study of tight junction strands in HEK293 cells and MDCK II cells expressing claudin-1 mutants in the second extracellular loop. Histochem. Cell Biol. 2009, 131(6):681-690.
16. Jia Q., Lee B., Clemens D.L., Bowen R.A., Horwitz M.A. Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis. Vaccine 2009, 27(8):1216-1229.
17. Kraemer P.S., et al. Genome-wide screen in Francisella novicida for genes required for pulmonary and systemic infection in mice. Infect. Immun. 2009, 77(1):232-244.
18. Larsson P., et al. The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat. Genet. 2005, 37(2):153-159.
19. Law H.T., et al. Francisella tularensis Uses cholesterol and clathrin-based endocytic mechanisms to invade hepatocytes. Scientific Reports 2011, 1.
20. Ludu J.S., et al. The Francisella pathogenicity island protein PdpD is required for full virulence and associates with homologues of the type VI secretion system. J. Bacteriol. 2008, 190(13):4584-4595.
21. Nano F.E., Schmerk C. The Francisella Pathogenicity island. Ann. N. Y. Acad. Sci. 2007, 1105(1):122-137.
22. Nano F.E., et al. A Francisella tularensis pathogenicity island required for intramacrophage growth. J. Bacteriol. 2004, 186(19):6430-6436.
23. Ojeda S.S., et al. Rapid Dissemination of Francisella tularensis and the Effect of Route of Infection. BMC Microbiol. 2008, 8(1):215.
24. Petrosino J.F., et al. Chromosome rearrangement and diversification of Francisella tularensis revealed by the type B (OSU18) genome sequence. J. Bacteriol. 2006, 188(19):6977-6985.
25. Qin A., Mann B.J. Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. BMC Microbiol. 2006, 6:69.
26. Toyofuku T., et al. Intercellular calcium signaling via gap junction in connexin-43-transfected cells. J. Biol. Chem. 1998, 273(3):1519-1528.
27. US Centers for Disease Control and Prevention, Bioterrorism Agents/Diseases (by Category) | Emergency Preparedness & Response, 2009. US Center for Disease Control and Prevention Available at:, [Accessed October 14, 2012]. http://www.bt.cdc.gov/agent/agentlist-category.asp.
28. Van Putten J.P., Weel J.F., Grassmé H.U. Measurements of invasion by antibody labeling and electron microscopy. Methods Enzymol. 1994, 236:420-437.